Michael Gibney

feedback. When billionaire entrepreneur and venture capital investor Sean Parker launched the Parker Institute for Cancer Immunotherapy in 2016, a new wave of oncology medicines was breaking on the shores of the pharma industry. Checkpoint inhibitors like... See more

feedback. Biogen is on a mission to transform — from building a new headquarters in Kendall Square near Boston to further expanding the aperture beyond its multiple sclerosis beginnings — and emerging technologies are set to be key players in that effort.... See more

feedback. Dr. Patrizia Cavazzoni. Dr. Jacqueline Corrigan-Curay. Dr. George Tidmarsh. Dr. Richard Pazdur. Dr. Tracy Beth Høeg. These five doctors have one major thing in common: They have all been director of the Center for Drug Evaluation and Research th... See more

feedback. The year started strong for pharma M&A with Johnson & Johnson inking the largest deal of 2025 in the first two weeks of January. After that, no other matchup reached those heights again. But despite an M&A environment that hasn’t fir... See more

feedback. No pharma giant can thrive in a vacuum. While massive drugmakers like Eli Lilly grow through blockbuster product sales, they also rely on a wide network of earlier-stage biotechs to keep innovation wheels turning. As Lilly has developed into the... See more